Health · 16 July 2026

Your future Alzheimer's risk could be prevented

About 1,600 people at high risk of Alzheimer's will take a new drug called trontinemab in trials across the world. Scientists hope the monthly infusion, made by Swiss firm Roche, will prevent symptoms by removing brain plaques more effectively. Trontinemab could lead to Alzheimer's being treated preventively, similar to heart disease medications.

By BriefTea Editorial · 16 July 2026 at 1:22

Reported by Daily Express · How we write briefs

Get the app

More briefs

HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care HealthThousands of UK women get undiagnosed PTSD after childbirth More health stories → Browse all stories →